サマリー

アルファグルコシダーゼ阻害剤の世界市場 2022-2026 年
Technavioはαグルコシダーゼ阻害剤市場を監視しており、2022-2026年の間に5億6796万ドル、予測期間中にCAGR2.51％で加速して成長すると予測しています。当レポートでは、α-グルコシダーゼ阻害剤市場の全体分析、市場規模と予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、糖尿病に対する意識の高まりとイニシアチブの拡大、α-グルコシダーゼ阻害剤の利点に関する認識の高まり、世界的なダンピング症候群の有病率の上昇によって牽引されています。
αグルコシダーゼ阻害剤市場の分析には、疾患タイプセグメントと地理的展望が含まれます。
Technavioのαグルコシダーゼ阻害剤市場は、以下のようにセグメント化されています。
疾患タイプ別
- 2型糖尿病
- ダンピング症候群
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間におけるα-グルコシダーゼ阻害剤市場の成長を牽引する主要な理由の一つとして、老年人口の増加を挙げています。また、新規かつ改良されたαグルコシダーゼ阻害剤の入手可能性とαグルコシダーゼ阻害剤に関する研究開発の増加が、市場の大きな需要につながると思われます。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。α-グルコシダーゼ阻害剤市場に関する当レポートの対象領域は以下の通りです。
- α-グルコシダーゼ阻害剤の市場サイジング
- α-グルコシダーゼ阻害剤の市場予測
- α-グルコシダーゼ阻害剤市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上させることができるように設計されており、これに沿って本レポートでは、Anderson Hay and Grain Co. Inc.、AstraZeneca Plc、Bayer AG、BioVision Inc、Border Valley Trading、Bristol Myers Squibb Co.、C. H. Boehringer Sohn AG and Co.KG、Eli Lilly and Co.、GSK Plc、Glenmark Pharmaceuticals Ltd、Merck KGaA、Novartis AG、Novo Nordisk AS、Pfizer Inc、Sanofi、 Straight Healthcare、Sun Pharmaceutical Industries Ltd、Takeda Pharmaceutical Co.Ltd.また、αグルコシダーゼ阻害剤市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/alpha-glucosidase-inhibitors-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Disease Type
o 5.1 Market segments
o Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)
o 5.2 Comparison by Disease Type
o Exhibit 26: Chart on Comparison by Disease Type
o Exhibit 27: Data Table on Comparison by Disease Type
o 5.3 Type 2 diabetes - Market size and forecast 2021-2026
o Exhibit 28: Chart on Type 2 diabetes - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Type 2 diabetes - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Type 2 diabetes - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Type 2 diabetes - Year-over-year growth 2021-2026 (%)
o 5.4 Dumping syndrome - Market size and forecast 2021-2026
o Exhibit 32: Chart on Dumping syndrome - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Dumping syndrome - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Dumping syndrome - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Dumping syndrome - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Disease Type
o Exhibit 36: Market opportunity by Disease Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 Japan - Market size and forecast 2021-2026
o Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Anderson Hay and Grain Co. Inc.
o Exhibit 85: Anderson Hay and Grain Co. Inc. - Overview
o Exhibit 86: Anderson Hay and Grain Co. Inc. - Product / Service
o Exhibit 87: Anderson Hay and Grain Co. Inc. - Key offerings
o 10.4 Bayer AG
o Exhibit 88: Bayer AG - Overview
o Exhibit 89: Bayer AG - Business segments
o Exhibit 90: Bayer AG - Key offerings
o Exhibit 91: Bayer AG - Segment focus
o 10.5 Border Valley Trading
o Exhibit 92: Border Valley Trading - Overview
o Exhibit 93: Border Valley Trading - Product / Service
o Exhibit 94: Border Valley Trading - Key offerings
o 10.6 Eli Lilly and Co.
o Exhibit 95: Eli Lilly and Co. - Overview
o Exhibit 96: Eli Lilly and Co. - Product / Service
o Exhibit 97: Eli Lilly and Co. - Key offerings
o 10.7 Glenmark Pharmaceuticals Ltd
o Exhibit 98: Glenmark Pharmaceuticals Ltd - Overview
o Exhibit 99: Glenmark Pharmaceuticals Ltd - Product / Service
o Exhibit 100: Glenmark Pharmaceuticals Ltd - Key offerings
o 10.8 Merck KGaA
o Exhibit 101: Merck KGaA - Overview
o Exhibit 102: Merck KGaA - Business segments
o Exhibit 103: Merck KGaA - Key news
o Exhibit 104: Merck KGaA - Key offerings
o Exhibit 105: Merck KGaA - Segment focus
o 10.9 Pfizer Inc.
o Exhibit 106: Pfizer Inc. - Overview
o Exhibit 107: Pfizer Inc. - Product / Service
o Exhibit 108: Pfizer Inc. - Key news
o Exhibit 109: Pfizer Inc. - Key offerings
o 10.10 Sanofi
o Exhibit 110: Sanofi - Overview
o Exhibit 111: Sanofi - Business segments
o Exhibit 112: Sanofi - Key news
o Exhibit 113: Sanofi - Key offerings
o Exhibit 114: Sanofi - Segment focus
o 10.11 Sun Pharmaceutical Industries Ltd.
o Exhibit 115: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 116: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 117: Sun Pharmaceutical Industries Ltd. - Key offerings
o 10.12 Takeda Pharmaceutical Co. Ltd.
o Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 122: Inclusions checklist
o Exhibit 123: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 124: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 125: Research methodology
o Exhibit 126: Validation techniques employed for market sizing
o Exhibit 127: Information sources
o 11.5 List of abbreviations
o Exhibit 128: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Disease Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Disease Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Disease Type
Exhibits27: Data Table on Comparison by Disease Type
Exhibits28: Chart on Type 2 diabetes - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Type 2 diabetes - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Type 2 diabetes - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Type 2 diabetes - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Dumping syndrome - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Dumping syndrome - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Dumping syndrome - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Dumping syndrome - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Disease Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Anderson Hay and Grain Co. Inc. - Overview
Exhibits86: Anderson Hay and Grain Co. Inc. - Product / Service
Exhibits87: Anderson Hay and Grain Co. Inc. - Key offerings
Exhibits88: Bayer AG - Overview
Exhibits89: Bayer AG - Business segments
Exhibits90: Bayer AG - Key offerings
Exhibits91: Bayer AG - Segment focus
Exhibits92: Border Valley Trading - Overview
Exhibits93: Border Valley Trading - Product / Service
Exhibits94: Border Valley Trading - Key offerings
Exhibits95: Eli Lilly and Co. - Overview
Exhibits96: Eli Lilly and Co. - Product / Service
Exhibits97: Eli Lilly and Co. - Key offerings
Exhibits98: Glenmark Pharmaceuticals Ltd - Overview
Exhibits99: Glenmark Pharmaceuticals Ltd - Product / Service
Exhibits100: Glenmark Pharmaceuticals Ltd - Key offerings
Exhibits101: Merck KGaA - Overview
Exhibits102: Merck KGaA - Business segments
Exhibits103: Merck KGaA - Key news
Exhibits104: Merck KGaA - Key offerings
Exhibits105: Merck KGaA - Segment focus
Exhibits106: Pfizer Inc. - Overview
Exhibits107: Pfizer Inc. - Product / Service
Exhibits108: Pfizer Inc. - Key news
Exhibits109: Pfizer Inc. - Key offerings
Exhibits110: Sanofi - Overview
Exhibits111: Sanofi - Business segments
Exhibits112: Sanofi - Key news
Exhibits113: Sanofi - Key offerings
Exhibits114: Sanofi - Segment focus
Exhibits115: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits116: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits117: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits118: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits119: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits120: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits121: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits122: Inclusions checklist
Exhibits123: Exclusions checklist
Exhibits124: Currency conversion rates for US$
Exhibits125: Research methodology
Exhibits126: Validation techniques employed for market sizing
Exhibits127: Information sources
Exhibits128: List of abbreviations